Author pages are created from data sourced from our academic publisher partnerships and public sources.
A phase I trial of tocoferol monoglucoside in patients undergoing hemi-body radiation.
- N. Huilgol, C. Nair, P. Merhotra, V. Kagiya
- Journal of cancer research and therapeutics
- 31 December 2005
PURPOSE To evaluate Tocoferol monoglucoside (TMG), a water soluble vit. E. in a phase I trial, as a radiation protector in those undergoing hemi-body radiation for disseminated disease. MATERIALS… Expand